iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease

Authors

Keywords

Alzheimer’s disease, patient iPS cells, amyloid β, compound screening, drug repositioning, chemical clustering, anti-Aβ cocktail, in vitro, trial

Journal

Volume 21, Issue 8, Pages 2304-2312

Publisher

Elsevier BV

Online

2017-11-22

DOI

10.1016/j.celrep.2017.10.109

Contact the author

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now